Navigation Links
Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
Date:11/29/2007

VYVANSE were decreased appetite, difficulty falling asleep, stomachache, and irritability.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette's syndrome have been associated with use of drugs of this type. Tell the doctor if your child has blurred vision while taking VYVANSE.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions.

Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com.

THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward- looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGFbeta3) and GA-GCB (velaglucerase alfa); manufactu
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
3. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May ... filed an amendment to regulate vaccines containing mercury in ... buy, sell, manufacture, deliver, import, administer or distribute any ... or inorganic mercury per milliliter for children younger than ...
... 2011 Kinex Pharmaceuticals, LLC announced today that Dr. Allen ... decided to step aside as CEO. Dr. ... from a start-up biotechnology company with only a technology platform ... pre-IND to phase 2 developments. The recent collaboration established with ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 2The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 3
(Date:8/29/2014)... Angeles, CA (PRWEB) August 29, 2014 ... the expert knowledge and authenticity of its doctors. ... that only the most renowned doctors in their field ... helps to assure patients have a direct link to ... Patients and doctors will be able to communicate through ...
(Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 ... by Daily Gossip reveals that the new program ... , The method was created by a ... this method to overcome the disturbing problem. Manuel ... developing and using this system. , Learn ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 DailyGossip.org ... This is an absolutely unique method of curing multiple ... new program was created by Dr. Gary M. Levin, ... health specialist started to become interested in alternative remedies ... that classical remedies cannot be effective in all cases ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Dr. ... his plan to rename his practice to Parsa Mohebi ... Restoration has served the needs of hair loss patients ... traveled to its centers in Los Angeles, Beverly Hills, ... surgical and non surgical treatments, many of which Dr. ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Developed as ... DoudouneCanadienneGoosePasCher.fr’s high quality Canada Goose products offer ... when working on Arctic runways. The company’s Canada ... jackets in the current market. Additionally, the firm has ... special offer. , At present, all high quality ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
... global food crisis that started in 2007, leading to ... are malnourished. The Institute of Medicine will convene ... implications of the food crisis on nutrition and health. ... crisis and escalating food prices on nutrition, country and ...
... , , VIRGINIA BEACH, Va., July 7 ... with Arthrex, Inc., has released the KinetiGraft Tendon, the ... new options for ligament and tendon reconstruction. , ... medicine physicians another alternative in repairing patient injuries. KinetiGraft ...
... July 7 Whole Foods Market (Nasdaq: ... announced a commitment to the Non-GMO Project - a ... breeders and consumers - to use the Non-GMO,s Product ... private label products. , , (Photo: ...
... WILTON, Conn., July 7 Startech Environmental Corp. (OTC BB: STHK), ... shareholders not to take any action with respect to the commencement ... Holdings LLC to purchase all of the outstanding shares of Startech ... board of directors today said that it will carefully review the ...
... Premier Research Group Limited, the international clinical research ... Data Capture Onsite 4.5.3, the enhanced version of Oracle,s ... of trial sponsors as well as investigative site personnel. ... tradition of Oracle Clinical data management as an early ...
... (FHC) (Nasdaq-CM: FHCO) today announced that Fortune has ... small companies in America. Fortune,s annual top-100 list rates ... their annualized revenue growth and their total return to investors. ... recognized the core strengths and growth potential of Female Health ...
Cached Medicine News:Health News:LifeNet Health Launches Sports Medicine Bio-Implants 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 3Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 4Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 3Health News:Premier Research Launches Oracle(R) Remote Data Capture Onsite 4.5.3 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 3Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 4
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... The Illuminated Phoroptor features lighted dials ... to perform refractions in the darkened setting ... pen light and leave the lights off ... features lighted sphere, cylinder power and cylinder ...
... The Reichert CT200 Tonometer ... the XCEL 250 and XCEL ... also compatible with other Zeiss-style ... mounted on the top of ...
Medicine Products: